RT Journal Article SR Electronic(1) A1 Wenzler, Eric A1 Chandrasekaran, Vidhya A1 Salvador, Patricia A1 Anwar, Muhammad A1 Pancholi, Preeti A1 McGwire, Bradford S.YR 2015 T1 Clinical and microbiological outcomes in patients with Streptococcus anginosus group bacteraemia identified through use of a rapid microarray assay JF Journal of Medical Microbiology, VO 64 IS 11 SP 1369 OP 1374 DO https://doi.org/10.1099/jmm.0.000176 PB Microbiology Society, SN 1473-5644, AB Limited data exist evaluating outcomes in patients with serious Streptococcus anginosus group infections, particularly bacteraemia. A retrospective, single-centre cohort study was conducted to characterize potential risk factors along with clinical and microbiological outcomes in patients with S. anginosus group bacteraemia (SAGB). Adult inpatients with SAGB identified using the Verigene Gram-positive blood culture assay between March 2013 and April 2014 were included. Patients aged ≤ 18 or >89 years, those with SAGB identified at an outside facility and those who were incarcerated were excluded. Differences between groups were explored using a Wilcoxon rank-sum test, χ2 test, Student's t-test or Fisher's exact test as appropriate and a two-tailed P value of ≤ 0.05 was considered statistically significant. The 34 patients who met the inclusion criteria were 57 ± 14 (mean ± sd) years old and had a median Charlson co-morbidity index of 4 [interquartile range (IQR) 1–6] and 10 (29 %) were immunosuppressed at baseline. Almost half (47 %) had received antibiotics in the previous 90 days. Twelve (35 %) patients had gastrointestinal malignancies and the commonest source of bacteraemia was the gastrointestinal tract (53 %). The primary species responsible for SAGB was S. anginosus (68 %), and overall susceptibility to penicillin was 91 %. Patients were most often treated with a β-lactam/β-lactamase inhibitor combination (36 %) for a duration of 8 (IQR 4–13) days. Length of stay (LOS) and infection-related LOS were 10 (IQR 5–17) and 9 (IQR 4–12) days, respectively. Twenty [59 %] patients achieved a clinical cure, while 29 (85 %) achieved a microbiological cure. Four (12 %) patients died and one patient was readmitted within 30 days. In the largest cohort of patients with SAGB to date, gastrointestinal malignancies may have been an important risk factor for SAGB, while rapid identification via a microarray assay likely contributed to improved disease recognition and timely pharmacological and non-pharmacological therapy., UL https://www.microbiologyresearch.org/content/journal/jmm/10.1099/jmm.0.000176